Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.982,43
0,30%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gritstone bio Inc (GRTS) Gritstone bio Inc (GRTS) Notizie

Gritstone bio Inc

GRTS
0,80
-0,1728 (-17,76%)
11 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/5/202422:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:07EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEGritstone bio Reports First Quarter 2024 Financial Results..
02/5/202422:05GLOBEGritstone bio to Report First Quarter 2024 Financial Results..
30/4/202413:00GLOBEGritstone bio Highlights the Durability and Potential Broad..
29/4/202413:00GLOBEGritstone bio Announces Appointment of Stephen Webster to..
15/4/202413:00GLOBENature Medicine Publishes Interim Results from Gritstone..
08/4/202414:00GLOBEGritstone bio to Participate in Upcoming Investor and..
08/4/202413:00GLOBEGritstone bio Presents Improvements to EDGE™ Platform at..
02/4/202405:00GLOBEGritstone bio Announces Pricing of $32.5 Million..
01/4/202422:10GLOBEGritstone bio Announces Proposed Public Offering
01/4/202422:01GLOBEGritstone bio Announces Positive Preliminary..
05/3/202422:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202422:08EDGAR2Form 8-K - Current report
05/3/202422:05GLOBEGritstone bio Reports Fourth Quarter and Full Year 2023..
29/2/202422:05GLOBEGritstone bio Announces Workforce Reduction 
21/2/202413:00GLOBEGritstone bio to Participate in Upcoming Investor and..
13/2/202418:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202413:39EDGAR2Form 8-K - Current report
12/2/202413:00GLOBEGritstone bio Announces Update to Comparative Phase 2b..
08/2/202422:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
06/2/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202413:00GLOBEGritstone bio to Participate in Upcoming Investor Conference
10/1/202422:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
02/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/12/202322:06EDGAR2Form S-3 - Registration statement under Securities Act of..
07/12/202322:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
20/11/202313:00GLOBEGritstone bio to Participate in Upcoming Investor..
08/11/202322:06EDGAR2Form 8-K - Current report
08/11/202322:05GLOBEGritstone bio Reports Third Quarter 2023 Financial Results..
07/11/202322:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
12/10/202323:00GLOBEGenevant Sciences LNP Technology Used in samRNA Covid-19..
11/10/202313:10GLOBEPresentations at IDWeek 2023 Highlight Potentially..
10/10/202313:00GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
04/10/202322:05GLOBEGritstone bio Announces Presentations from Phase 1 Studies..
27/9/202322:07EDGAR2Form 8-K - Current report
27/9/202322:01GLOBEGritstone bio Awarded BARDA Contract to Conduct Comparative..
13/9/202322:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
05/9/202313:00GLOBEGritstone bio to Participate in Upcoming Investor..
16/8/202322:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
15/8/202313:21EDGAR2Form 8-K - Current report
15/8/202313:00GLOBEGritstone bio and Genevant Sciences Announce Option and..
09/8/202322:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:08EDGAR2Form 8-K - Current report
09/8/202322:05GLOBEGritstone bio Reports Second Quarter 2023 Financial Results..
Apertura: 0,8501 Min: 0,7821 Max: 0,8712
Chiusura: 0,9728

La tua Cronologia

NASDAQ
GRTS
Gritstone bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network